Ganetespib (STA-9090) augments sorafenib efficacy via necroptosis induction in hepatocellular carcinoma: Implications from preclinical data for a novel therapeutic approach

索拉非尼 坏死性下垂 肝细胞癌 癌症研究 自噬 缺氧(环境) 药理学 细胞凋亡 医学 MAPK/ERK通路 程序性细胞死亡 信号转导 化学 生物化学 有机化学 氧气
作者
Sameh Saber,Alexandru Madalin Hasan,Osama A. Mohammed,Lobna A. Saleh,Abdullah A. Hashish,Mohannad Mohammad S. Alamri,Ahmed Ameer,Jaber Alfaifi,Ahmed Senbel,Adel Mohamed Aboregela,Tarig Babikir Algak Khalid,Mustafa Ahmed Abdel‐Reheim,Simona Cavalu
出处
期刊:Biomedicine & Pharmacotherapy [Elsevier BV]
卷期号:164: 114918-114918 被引量:27
标识
DOI:10.1016/j.biopha.2023.114918
摘要

Sorafenib, a multikinase inhibitor, is a first-line treatment for advanced hepatocellular carcinoma, but its long-term effectiveness is limited by the emergence of resistance mechanisms. One such mechanism is the reduction of microvessel density and intratumoral hypoxia caused by prolonged sorafenib treatment. Our research has demonstrated that HSP90 plays a critical role in conferring resistance to sorafenib in HepG2 cells under hypoxic conditions and N-Nitrosodiethylamine-exposed mice as well. This occurs through the inhibition of necroptosis on the one hand and the stabilization of HIF-1α on the other hand. To augment the effects of sorafenib, we investigated the use of ganetespib, an HSP90 inhibitor. We found that ganetespib activated necroptosis and destabilized HIF-1α under hypoxia, thus enhancing the effectiveness of sorafenib. Additionally, we discovered that LAMP2 aids in the degradation of MLKL, which is the mediator of necroptosis, through the chaperone-mediated autophagy pathway. Interestingly, we observed a significant negative correlation between LAMP2 and MLKL. These effects resulted in a reduction in the number of surface nodules and liver index, indicating a regression in tumor production rates in mice with HCC. Furthermore, AFP levels decreased. Combining ganetespib with sorafenib showed a synergistic cytotoxic effect and resulted in the accumulation of p62 and inhibition of macroautophagy. These findings suggest that the combined therapy of ganetespib and sorafenib may offer a promising approach for the treatment of hepatocellular carcinoma by activating necroptosis, inhibiting macroautophagy, and exhibiting a potential antiangiogenic effect. Overall, continued research is critical to establish the full therapeutic potential of this combination therapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
yyyyy完成签到 ,获得积分10
刚刚
满意的苑博完成签到,获得积分20
刚刚
FashionBoy的应助被wjswift采纳,获得10
刚刚
曾经的哲瀚完成签到,获得积分10
刚刚
务实寄松发布了新的文献求助10
刚刚
刚刚
风吹麦浪发布了新的文献求助10
刚刚
风吹麦浪发布了新的文献求助30
刚刚
1秒前
科研通AI6.3的应助被zs采纳,获得10
1秒前
gujianhua发布了新的文献求助10
1秒前
Maestro_S的应助被anbude采纳,获得10
1秒前
风吹麦浪发布了新的文献求助10
1秒前
maomao发布了新的文献求助10
1秒前
1秒前
1秒前
单纯的石头完成签到 ,获得积分10
1秒前
NexusExplorer的应助被Zengjx采纳,获得10
2秒前
知行者完成签到,获得积分10
2秒前
深情安青的应助被繁荣的傲南采纳,获得10
2秒前
风吹麦浪的应助被迪迪张采纳,获得10
2秒前
2秒前
蛋蛋完成签到,获得积分10
2秒前
嘟嘟咪发布了新的文献求助10
2秒前
2秒前
3秒前
HMO_eee完成签到,获得积分10
3秒前
别拿暗恋当饭吃完成签到 ,获得积分10
3秒前
3秒前
潇洒的如风完成签到,获得积分10
3秒前
从容水壶发布了新的文献求助10
4秒前
Hongdou完成签到,获得积分10
5秒前
zyn完成签到,获得积分10
5秒前
5秒前
5秒前
袁志阳发布了新的文献求助10
6秒前
英俊的铭的应助被aaaaaa采纳,获得10
6秒前
可可2326发布了新的文献求助10
7秒前
一YI发布了新的文献求助10
7秒前
SMQH完成签到,获得积分10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181014
求助须知:如何正确求助?哪些是违规求助? 9571039
关于积分的说明 21816042
捐赠科研通 7777369
什么是DOI,文献DOI怎么找? 3433378
关于科研通互助平台的介绍 2557621
邀请新用户注册赠送积分活动 2479385